Softwr

Healthcare · head to head

Phreesia vs Therapixel

Phreesia logo

Phreesia

Healthcare

Patient intake, registration and payments platform for medical practices

From
Free
Rated
-
Full reviewWebsite
Therapixel logo

Therapixel

Healthcare

French mammography AI with FDA clearances for 2D and tomosynthesis breast screening

From
On request
Rated
-
Full reviewWebsite

The short version

  • Only Phreesia has a free tier, so it costs nothing to try first.
  • Each has a real cost: Phreesia no price is published: the vendor states pricing is customised to organisation size, workflows and products used, and is given only as a tailored quote; Therapixel european and American regulatory positions were established under different regimes, and under the EU Medical Device Regulation this class of diagnostic AI faces a higher classification and notified body scrutiny, so European buyers must verify the current MDR certificate and expiry rather than relying on a legacy CE reference.
  • Prices and features above were last checked on 1 September 2026.

Where they differ

Only the attributes on which Phreesia and Therapixel actually diverge.

Attributes where Phreesia and Therapixel differ
AttributePhreesiaTherapixel
Starting priceFreeOn request
Pricing modelsubscriptionquote
Free tierYesNo

Identical on both: platforms (Web), user rating (Not yet rated), category (Healthcare).

What each one covers

Drawn from each product's published feature list. An absence here means we hold no record of it - not that the product lacks it.

Only in Phreesia

Nothing recorded that Therapixel does not also cover.

Only in Therapixel

  • MammoScreen 2D
  • MammoScreen DBT
  • One to ten suspicion score
  • Summary report
  • Workstation and PACS delivery
  • Reading workflow configurations

What people use each for

The jobs each tool is most often brought in to do.

Phreesia

  • Digital patient intake and registration ahead of an appointmentnot Therapixel
  • Collecting patient payments as part of the intake workflownot Therapixel
  • Automating clinical screening questionnaires at check-innot Therapixel

Therapixel

  • A European breast screening programme running mandatory double reading that wants to evaluate AI as a concurrent or second reader within what national guidance permitsnot Phreesia
  • An American breast centre that has moved to tomosynthesis and needs reading support on DBT specifically, which Therapixel holds a clearance fornot Phreesia
  • A screening service wanting a graded suspicion score rather than a binary flag so readers can calibrate their own thresholdnot Phreesia
  • A radiology group evaluating multiple mammography AI vendors head to head on their own historic case set before committingnot Phreesia

Where each one falls short

Documented limitations, not opinions. Every one is a constraint you would hit in normal use.

Phreesia

  • No price is published: the vendor states pricing is customised to organisation size, workflows and products used, and is given only as a tailored quote
  • The current free access to the Intake platform is time limited and ends on 31 December 2026, with the rate that follows undisclosed
  • A buyer must book a demo before receiving any figure

Therapixel

  • European and American regulatory positions were established under different regimes, and under the EU Medical Device Regulation this class of diagnostic AI faces a higher classification and notified body scrutiny, so European buyers must verify the current MDR certificate and expiry rather than relying on a legacy CE reference.
  • MammoScreen does mammography only, so a hospital wanting AI across head CT, chest and breast needs several vendors and several PACS integrations, or an orchestration layer bought from someone else.
  • Therapixel is a small French company competing against Hologic and iCAD, which have incumbency inside the mammography reading workstation, so integration into an American breast centre is more work than it is for the workstation vendor own AI.
  • Detection performance is sensitive to the mammography unit vendor and acquisition protocol, so published results do not transfer between estates and each site needs local validation it must fund itself.
  • Whether AI can substitute for one of two human readers is a national workforce and liability question, not a product capability, so the labour saving that justifies the purchase in one country is not permitted in another.

Pricing, plan by plan

Phreesia

Free

No published plan breakdown. See the Phreesia review.

Therapixel

On request
  • MammoScreen$undefined/year
    • Priced per examination or by annual screening volume
    • 2D and tomosynthesis licensed by the versions cleared for each
    • Cloud or on premises deployment quoted differently

Which should you pick?

Choose Phreesia if

  • You want to start without paying.
Phreesia review

Choose Therapixel if

  • You need mammoscreen 2d.
  • You also want mammoscreen dbt.
Therapixel review

Questions people ask

Is Phreesia or Therapixel better?
Neither clearly leads. Phreesia starts at Free and Therapixel at On request, and user ratings are close enough to be indistinguishable. Choose on capability and platform support.
Which is cheaper, Phreesia or Therapixel?
Phreesia has a free tier; the other does not. Paid plans start at Free for Phreesia and On request for Therapixel.
Does Phreesia or Therapixel run on more platforms?
Both run on Web, so platform support will not decide this one for you.
Can I use Phreesia for free?
Yes. Phreesia has a free tier, so you can try it without paying. Therapixel starts at On request.
What is Phreesia best used for?
Phreesia is most often used for digital patient intake and registration ahead of an appointment, collecting patient payments as part of the intake workflow, automating clinical screening questionnaires at check-in. Of those, digital patient intake and registration ahead of an appointment and collecting patient payments as part of the intake workflow are not what Therapixel is typically brought in for.
What can Phreesia do that Therapixel cannot?
Therapixel covers MammoScreen 2D, MammoScreen DBT, One to ten suspicion score, Summary report.

Answered from the vendors’ own pages

Phreesia: Is there a free version of Phreesia?

Phreesia offers free access to the complete Phreesia Intake platform through December 31, 2026. Standard subscription pricing begins January 1, 2027, with transparent pricing and no per-message charges or hidden fees.

Source
Therapixel: Is MammoScreen FDA cleared?

Yes. It holds 510(k) clearance K192854 for two dimensional mammography from July 2020, a November 2021 clearance for digital breast tomosynthesis, and two further clearances in October 2024 for later versions.

Phreesia: How is Phreesia priced?

Phreesia pricing is customized based on organization size, workflows, and products used. The company offers transparent subscription pricing with no per-message charges. Specific pricing requires contacting the company via their demo request form for a tailored quote.

Source
Therapixel: Is it CE marked?

Yes, but European buyers should ask specifically for the current certificate under the Medical Device Regulation and its expiry date, because this class of diagnostic AI moved to a higher classification under MDR.

Therapixel: What does the one to ten score mean?

It is a graded suspicion score per finding and per study, designed to be integrated alongside a radiologist BI-RADS assessment rather than treated as a positive or negative result.

Therapixel: Does it cover anything besides mammography?

No. It is a mammography product only, including tomosynthesis. Other body regions need a different vendor.

Share

Related pages

More on Phreesia

More on Therapixel

Keep looking

Other head to heads